AnalystBook Research · Company Intelligence

BRANDYWINE REALTY TRUST

BDNNYSE

Built from BRANDYWINE REALTY TRUST's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Brandywine's loss narrowed, but revenue, cash from ops, margins, debt, and equity all moved the wrong way.

The read at a glance✓ Audited against SEC data
  • Business mixOffice, lab, residential, and mixed-use REITNote
  • RevenueRevenue fell 4.2%Watch
  • ProfitabilityNet loss narrowed to $178.2MNote
  • CashCash from ops fell 35.6%Watch
  • LeverageDebt rose 15.5%Watch
  • Insiders1 purchase / 1 saleNote
  • AccountingNo current forensic screen in bundleNote

Business

Brandywine Realty Trust is a self-administered, self-managed REIT focused on office, life science/lab, residential, and mixed-use properties.

Where the revenue comes from

Fiscal 2025, as BRANDYWINE REALTY TRUST reports it. History and quarterly detail are in the app.

  • Other$40.1M

Leadership changes

From BRANDYWINE REALTY TRUST's own filings, the day they're filed.

  • George D. Johnstone · President · departureeff. 2025-12-11
  • Terri A. Herubin · Directors · departureeff. 2024-05-31

Latest filings

  • 8-K · Company announcement2026-09-03
  • 8-K · Company announcement2026-08-17
  • 10-Q · Quarterly report2026-07-28
  • 8-K · Company announcement2026-07-23
  • 8-K · Company announcement2026-07-10
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about BRANDYWINE REALTY TRUST, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.